10/08/2025
USANA conducted a clinical study on its Celavive Resurfacing Serum to evaluate the efficacy and tolerance of the product. The results, announced in April, showed that Resurfacing Serum was well-tolerated by all subjects, and users showed statistically significant improvements in the appearance of their skin in two weeks.
"We are very pleased with the results of the Resurfacing Serum clinical study, and hope this will resonate well with our customer base," said Dr. Kathryn Armstrong, USANA's chief scientific officer. "Clinical studies are the best way to show the efficacy of a product, and the outcome of this study demonstrates the high quality of our Resurfacing Serum and USANA as a whole. As a company dedicated to science and quality, USANA invests a significant amount in research and development, so it is imperative we provide our customers with the most effective products possible."
Learn More: https://askthescientists.com/qa/resurfacing-serum-clinical-study/
